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Abstract
Background: Pyrosequencing can be applied for Single-Nucleotide-Polymorphism (SNP)-based pathogen typing or for
providing sequence information of short DNA stretches. However, for some pathogens molecular typing cannot be
performed relying on a single SNP or short sequence stretch, necessitating the consideration of several genomic regions. A
promising rapid approach is the simultaneous application of multiple sequencing primers, called multiplex pyrosequencing.
These primers generate a fingerprint-pyrogram which is constituted by the sum of all individual pyrograms originating from
each primer used.
Methods: To improve pyrosequencing-based pathogen typing, we have developed the software tool MultiPSQ that
expedites the analysis and evaluation of multiplex-pyrograms. As a proof of concept, a multiplex pyrosequencing assay for
the typing of orthopoxviruses was developed to analyse clinical samples diagnosed in the German Consultant Laboratory
for Poxviruses.
Results: The software tool MultiPSQ enabled the analysis of multiplex-pyrograms originating from various pyrosequencing
primers. Thus several target regions can be used for pathogen typing based on pyrosequencing. As shown with a proof of
concept assay, SNPs present in different orthopoxvirus strains could be identified correctly with two primers by MultiPSQ.
Conclusions: Software currently available is restricted to a fixed number of SNPs and sequencing primers, severely limiting
the usefulness of this technique. In contrast, our novel software MultiPSQ allows analysis of data from multiplex
pyrosequencing assays that contain any number of sequencing primers covering any number of polymorphisms.
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Introduction
One sensitive way to diagnose and subtype viral pathogens is
usually based on the detection of viral nucleic acids via PCR
amplification and subsequent DNA sequencing. For this purpose
Sanger sequencing is commonly used to determine the viral
species [1]. As a novel approach, pyrosequencing is a sequencing-
by-synthesis method allowing a fast and reliable detection of single
nucleotide polymorphisms (SNP) and sequence variations between
different species [2–6]. The pyrosequencing reaction relies on the
indirect detection of pyrophosphate that is released during
sequence-specific nucleotide incorporation. Pyrophosphate is
converted into discrete light signals proportional to the number
of identical nucleotides incorporated. Light signals are detected by
a charge-coupled device (CCD) camera and graphed in a so-called
pyrogram [7].
In some cases the differentiation of viral types is not possible by
detecting only one SNP or by considering only one sequence
stretch as the same sequence variation can be found in different
species. One approach to circumventing this problem is the use of
a pool of type-specific primers [8,9]. Another approach is the
detection of multiple sequence variations in one region or in
several regions in the same reaction by multiplex pyrosequencing
with several sequencing primers [7,10–12]. Here, one or more
DNA templates containing relevant sequence variations are
amplified by PCR using one biotinylated primer. Biotin-labelled
ssDNA strands are separated, followed by hybridization of two or
more sequencing primers. During pyrosequencing nucleotides are
dispensed in a defined order and incorporated following each
primer sequence. Since the signals from these simultaneous
sequencing reactions are generated at the same time, they overlap
to result in a single pyrogram (Figure 1). This pyrogram cannot be
used directly for sequence analysis as it is unknown from which of
the sequencing reactions the respective light signal originates.
However, the resulting single pyrogram can be used as a unique
fingerprint which is representative of a specific combination of
sequences.
Using software currently commercially available, analysis of
multiplex pyrograms is still challenging. Therefore, an in-house
software tool called MultiPSQ was developed to analyse and
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evaluate multiplex pyrosequencing results. To verify this software,
we developed a multiplex pyrosequencing assay identifying all
human-pathogenic orthopoxviruses (OPV). In addition to the
causative agent of smallpox, variola virus (VARV), the genus OPV
comprises diverse species including those transmitted zoonotically
and causing infections in humans, like monkeypox virus (MPXV),
cowpox virus (CPXV) and vaccinia virus (VACV). Further OPV
that do not infect humans are camelpox virus (CMLV), mousepox
virus (ECTV), raccoonpox virus and taterapox virus as well as
various unclassified OPV. As genomic sequences are well
conserved among OPV, virus type differentiation by only sequence
variations or SNPs within a single stretch of sequence is often
impossible. This makes OPV a good candidate for the demon-
stration of the utility of multiplex pyrosequencing and our tool’s
capabilities.
Materials and Methods
PCR with Biotinylated Primers
Each 25 ml reaction contained 3 ml of DNA, 1 6 PCR buffer
(Invitrogen), 4 mM of MgCl2, 200 nM of each dNTP, 800 nM of
each PCR primer (mPox F: gTgATTTTggCAATAgTCCATgT,
mPox R bio: Biotin-TAAAATggCCgAggAATTTg; Invitrogen)
and 1 U of Platinum Taq polymerase (Invitrogen). PCR was
performed in an Eppendorf Thermocycler (Eppendorf) with initial
denaturation at 95uC for 5 min, followed by 45 cycles of 95uC for
15 s, 54uC for 30 s and 72uC for 30 s and a final elongation at
72uC for 5 min.
Gelelectrophoresis and Quantification
To quantify amplified PCR product which represents the DNA
template for pyrosequencing, 2 ml of PCR product were mixed
with 1 ml of 66 loading buffer and loaded on a 1.5% Agarose gel
containing 0.5 mg/ml ethidium bromide. Equally, 2 ml of low mass
DNA ladder (Invitrogen) were loaded in parallel. Electrophoresis
was performed in 1 6 TAE buffer at 90 V for 30 min.
Quantification of DNA in resulting bands was done with
E.A.S.Y RH-3 software (Herolab).
Multiplex Pyrosequencing
Prior to sequencing, 20 to 25 ml of biotinylated PCR product
were captured with Streptavidin Sepharose beads and purified
with the PyroMark Q96 Vacuum Prep Workstation according to
the manufacturer’s instructions (Qiagen). For pyrosequencing,
10 pmol of each sequencing primer (mPox PS1: AAATTCCggA-
TACAT and mPox PS2: CTTgACAAAAATTgT) were hybrid-
ized to a single-stranded DNA template in the same well.
Multiplex pyrosequencing using both primers at the same time
for each template was performed with Pyro-Mark ID System
(Qiagen) with programmed nucleotide dispensation order of eight
cycles AGTC.
Viral DNA from Cell Culture and Clinical Samples
The multiplex PSQ assay was established with viral DNA
extracted from infected cell culture supernatants. DNA of the
following viral strains was used: CMLV CP-19, CPXV GuWi,
CPXV Brighton Red, CPXV Calpox, ECTV MP-Nü, MPXV
MSF (the latter two kindly provided by Dr. H. Meyer,
Bundeswehr Institute of Microbiology, Munich, Germany) and
VACV NYCBH (ATCC # VR-1536).
To verify the multiplex PSQ assay established, DNA from 34
clinical samples provided by the German Consultant Laboratory
for Poxviruses were analysed and differentiated with the novel
approach. Using real-time PCR approaches, 31 out of these 34
samples had previously been diagnosed as OPV positive, two as
parapoxvirus (PPV) positive and one as Molluscum contagiosum
virus (MOCV) positive. For 23 of 31 OPV samples the sequence of
the haemagglutinin (HA) gene had been determined by Sanger
sequencing, revealing one ECTV and 22 CPXV infections. For
eight OPV samples the HA sequence and therefore the OPV
species were unknown at this point of time.
Analysis of Multiplex Pyrograms
A cross-platform program MultiPSQ was developed in C++
using the Trolltech QT toolkit to perform the analysis of the
pyrograms. Initially, the data created by the pyrosequencer was
exported into an xml file using the Pyro-Mark ID System software.
This file included information about the wells used in the
experiment, the dispensation order and the times of injection of
the dNTPs for each well as well as the raw signals recorded during
the run. This xml file was loaded into the analysis software.
When reading the raw data of the wells, multiPSQ used
a moving average filter to smooth the data. The baseline corrected
value (Bi) at each point was found by computing an intermediate










where Rn is the value of the raw data vector at position n, w is the
window width (w= 30 in this case) and Bi is the value of the
corrected vector at position i. Peaks were detected, with a peak
Figure 1. Principle of multiplex pyrosequencing. Several sequencing primers are used in a single reaction. The incorporation of nucleotides
following each of the primers independently leads to the generation of light signals. These signals overlap in the final pyrogram, resulting in
a characteristic fingerprint. Changes in any of the single sequences lead to a change in the fingerprint which allows classification based on SNPs from
different regions of a PCR product or even from different PCR products.
doi:10.1371/journal.pone.0060055.g001
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being defined as a point which on the one hand was a local
maximum, preceded by at least three monotonously rising points,
followed by at least three monotonously falling points. On the
other hand, it had to be close to a known dNTP dispensation time.
Given that no significant signal decline was observed when
analyzing fragments up to 30 flows in length, no correction for
signal decline was performed. Once the data had been read and
preprocessed, multiPSQ showed a list of used wells at the top and
both raw and preprocessed data for the selected well at the bottom
(Figure S1). The signals of either a single well or all wells could
then be analyzed by clicking the ‘‘Analyze’’ or ‘‘Analyze all’’
buttons, respectively. The analysis was performed in five steps:
Table 1. Comparative results of multiplex pyrosequencing and Sanger sequencing.
Sample # Species DNA source OPV PCR Sanger sequencing Pyrosequencing
1 banded mongoose skin + CPXV CPXV
2 cat scab + CPXV CPXV
3 cat swab + CPXV CPXV
4 dog tissue, paraffin + n.d. CPXV
5 human swab + CPXV CPXV
6 human scab + n.d. CPXV
7 human swab + CPXV CPXV
8 human swab + CPXV CPXV
9 human ichor + CPXV CPXV
10 human swab + CPXV CPXV
11 human skin + CPXV CPXV
12 human scab + n.d. CPXV
13 human scab + CPXV CPXV
14 human cornea + CPXV CPXV
15 human tissue + CPXV CPXV
16 human tissue, paraffin + n.d. CPXV
17 human tissue + n.d. CPXV
18 human swab + n.d. CPXV
19 human tissue + CPXV CPXV
20 human scab + CPXV CPXV
21 human swab + n.d. CPXV
22 human lymph node + CPXV CPXV
23 human glove + CPXV CPXV
24 human ichor + CPXV CPXV
25 jaguarundi skin + CPXV CPXV
26 mara eye + n.d. CPXV
27 mouse lung + ECTV ECTV
28 rat swab + CPXV CPXV
29 rat skin + CPXV CPXV
30 rat lung + CPXV CPXV
31 rat swab + CPXV VACV
32 human swab 2 PPV 2
33 human serum 2 PPV 2
34 human swab 2 MOCV 2
35 cell culture + CMLV CMLV
36 cell culture + CPXV CPXV
37 cell culture + CPXV CPXV
38 cell culture + CPXV CPXV
39 cell culture + ECTV ECTV
40 cell culture + MPXV MPXV
41 cell culture + VACV VACV
+ positive PCR result; 2 negative PCR result; n.d. not done. Sanger classification is based on sequencing of a ,960 bp fragment of the HA gene, except for PPV and
MOCV which are not OPV (thus also yielding no signal in the OPV PCR).
doi:10.1371/journal.pone.0060055.t001
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Calculation of possible pyrograms. MultiPSQ read the
definition of the assay from a primer file and, given the
dispensation order of the loaded experiment, calculated the
pyrogram which would have been expected from each of the
primers in each organism defined in the assay. The plain text
primer file can be exported from the program mPSQed [13] for
any multiplex pyrosequencing assay created therein or it can be
created by hand following the instructions in the README file
which is distributed together with multiPSQ.
Filtering of wells. To make sure that only wells containing
a meaningful signal were analyzed, two criteria were defined
which had to be fulfilled by the raw data from each well before it
was considered for further analysis: A peak must have occurred at
least once every four cycles (as only four different bases are
dispensed periodically), and two consecutive peaks were not
generated by an injection of the same base. If one of these
anomalies occurred, the well was not considered in the following
calculations and was classified as ‘‘suspected NTC’’ (non-template
control).
Fitting of fingerprints. The pyrogram generated during the
experiment could be seen as a vector of signal strengths which, if
an organism defined in the assay was sequenced, must have been
a linear combination of the pyrograms expected for that organism.
Since the different sequencing primers could contribute differently






where the vector F is the fingerprint with each element of F
representing the signal intensity following the dispensation of
a base, n is the number of pyrosequencing primers in the assay, the
vector Xi is the expected pyrogram of the i
th pyrosequencing
primer with each element of Xi representing the expected signal
intensity following the dispensation of a base given the dispensa-
tion order of the current experiment, and ai is the factor with
which the ith pyrosequencing primer contributed to the finger-
print. Since neither the PCR amplification efficiencies nor the
sequencing efficiencies of the different sequenced fragments
relative to each other are known, it is impossible to pre-define ai
for any of the pyrosequencing primers. However, the values of F
and Xi are known from the raw data and the assay definition file.
Thus, as long as the number of dispensation events during the
sequencing is larger than the number n of pyrosequencing primers
used simultaneously in the experiment, the formula above
describes an overdetermined system. Thus the set of factors a for
each of the primers which allows the expected pyrograms to best
fit the raw data could be calculated using the linear least squares
method. Since a negative contribution of an amplicon to the signal
is not biologically plausible, fingerprints for which the calculation
yielded a negative value for any of the factors ai were discarded at
this point. This constraint additionally increases the power of the
least squares method, facilitating the recovery of the correct factors
ai even in the presence of noise [14].
Filtering of fingerprints. If a peak was expected in the
fingerprint but no peak could be detected in the raw data the
fingerprint was discarded.
Determination of final classification. After the filtering
step, the fingerprint which explained the peaks in the raw data
with the highest R2 was defined as the most likely fingerprint. In
order to assess the quality of this best fit, each assay can be
calibrated using a plate with known species in each well. During
calibration, the R2 of the best-fitting fingerprint for each of the







Where R2known is the mean R
2 of the best fit of the wells containing
species defined in the assay and R2unknown is the mean R
2 of the best
fit of the wells containing species not defined in the assay. In
following analyses, any well where the R2 of the best-fitting
fingerprint is lower than Rcut is classified as ‘‘unknown’’. To ensure
that the identified cutoff is correct, following calibration a leave-
one-out analysis is performed over the whole plate. If, during the
leave-one-out, any well is misclassified, the user is provided with
a list of misclassified wells and warned that classification using the
given assay is likely to be unreliable. Otherwise, the determined
Rcut is saved to the assay definition file so that it can be used in
subsequent analyses.
It is possible to perform classification without prior calibration.
In that case, a default cutoff of 0.5 is used. However, every time an
analysis is performed using an uncalibrated assay, the user is given
a warning and is reminded to perform calibration to ensure valid
results.
Since the algorithm only fits the raw signals to pyrograms
expected from known, pre-defined sequences, a strain containing
novel SNPs will be classified as ‘‘unknown’’. The identification of
sequences similar, but not identical to the predefined set is not
possible since, as described above and shown in Figure 1, it is not
possible to reconstruct the sequences from which a multiplex
pyrosequencing fingerprint was created without a priori in-
formation about the possible starting sequences.
The results of the analysis for the selected well are shown in the
top area of multiPSQ, along with the optimal factors ai determined
for the most likely fingerprint. For all wells, the analysis result is
color-coded in the well selection area (Figure S1).
Results
Design of the Multiplex Pyrosequencing Assay
Critical steps in designing a multiplex pyrosequencing assay
were the identification of suitable sequence variations and the
respective selection of sequencing primers in combination with an
optimal nucleotide dispensation order. Suitable SNPs could be
identified by the following strategy: First, all relevant known
sequences (sequences of 89 OPV genomes available from NCBI
and 24 full genome sequences generated in-house which have not
been published yet, see Table S1) were aligned. Then the
sequences were grouped by species. Potentially interesting SNPs
could be found at those positions in the alignment which are fully
conserved within each of the individual groups but not fully
conserved across the groups to be differentiated. Ideally, regions in
the alignment should be identified which contain several such
representative SNPs within a stretch of only a few bases, as several
SNPs could then be sequenced with a single primer. Once
characteristic SNPs had been found for each group, the
pyrosequencing primers had to be positioned in a way that all of
the SNPs could be sequenced with just a few sequencing cycles.
Finally, the resulting fingerprints (Figure 1) had to be calculated to
ensure that each group’s fingerprint was indeed unique. Because of
the way the fingerprints were generated, it was possible for signals
to mask each other. For instance, if one of the characteristic SNPs
was the deletion of an A and another characteristic SNP –
sequenced by a different primer – was the insertion of an A, these
A Software for n-Plexed Pyrosequencing Reactions
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two SNPs would cancel out in the fingerprint if both ‘‘As’’ were
sequenced in the same cycle. This problem could be solved by
moving one of the primers so that one of them generates the
sequence of the SNP in a different cycle. Obviously careful
positioning of the pyrosequencing primers was of utmost
importance. Specialized software had been developed in-house
to aid in this design process [13].
The analysis and classification of pyrograms generated from
such multiplex pyrosequencing assays was also challenging. Since
software currently available was limited to a fixed number of SNPs
and sequencing primers, we have developed our own software
tool, multiPSQ, for data analysis. MultiPSQ was developed in
C++ using the QT toolkit. Source code and binaries are available
for download together with exemplary data from http://
sourceforge.net/projects/multipsq/.
Differentiation of Orthopoxviruses
In the case of OPV differentiation, pyrosequencing of one PCR
product with two sequencing primers resulted in species-specific
fingerprints for all OPV species tested (Figure 2). Samples with
non-OPV template were correctly determined as ‘‘unknown’’
while the non-template control was truly negative. In addition to
cell culture-derived virus stocks, 34 clinical samples from the
German Consultant Laboratory for Poxviruses were analyzed with
the new multiplex PSQ assay (Table 1). Pyrosequencing results
were compared to conventional Sanger sequencing results,
identifying 22 clinical samples as CPXV or ECTV positive,
respectively, with both methods. Eight samples, for which no
Sanger sequence was available at that time, were identified as
CPXV positive using multiplex PSQ. In one case Sanger
sequencing and pyrosequencing showed different results, classify-
ing sample number 31 as CPXV or VACV positive, respectively.
Examination of the regions used in the multiplex PSQ assay
showed that sample 31 indeed carries all of the SNPs expected for
VACV rather than for CPXV. However, phylogenetic analysis of
the whole Sanger sequence showed sample 31 clearly clustering
with CPXV. This means that the primers used in this work cannot
be used to differentiate between CPXV and VACV since CPXV
strains carrying the VACV SNPs exist. Still, the SNPs present in
the sequence were correctly identified by the algorithm. Given that
this work does not aim at creating a new diagnostic assay but
rather at proving that relevant SNPs can be extracted from
multiplex PSQ signals, and SNP information was indeed correctly
identified, we consider this discrepancy in classification un-
problematic.
Non-OPV species such as PPV and MOCV were identified as
negative.
Discussion
In contrast to laborious and time-consuming Sanger sequencing
which is usually done to identify and type pathogens following
PCR, pyrosequencing represents a fast and reliable alternative
Figure 2. Fingerprints and species classification by the OPV multiplex PSQ assay. Each OPV species resulted in a slightly different
fingerprint allowing a definite identification. Non-OPV template is determined as ‘‘unknown’’ and non-template control is identified as ‘‘NTC’’.
doi:10.1371/journal.pone.0060055.g002
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method. It allows sequence generation and pathogen identification
in less than one hour from preparation of PCR products to final
sequence. However, due to the underlying mechanism of
sequencing-by-synthesis, sequences generated by pyrosequencing
are usually short (up to 80 nucleotides) [6,15]. Therefore,
discrimination of more than two closely related organisms that
differ only in a few but non-conserved SNPs is not possible with
conventional pyrosequencing. To circumvent this problem, the
generation of sequences starting from more than one primer leads
to specific sequence fingerprints, enabling pathogen typing despite
non-conserved SNPs that are representative for a respective group.
Recently, such a multiplex pyrosequencing assay has been
developed e.g. for genotyping hepatitis C virus [11].
Multiplex pyrosequencing is a versatile technology which can be
used for quick and easy classification of samples based on a large
set of different SNPs. The design of assays and the analysis of the
resulting data are, however, neither trivial nor are they supported
by common software. In this paper, we present the program
MultiPSQ which complements the analysis capabilities of the
Qiagen pyrosequencing platform. We demonstrate the capability
of this technology to tackle non-trivial tasks by applying it to the
identification and classification of all human-pathogenic OPV.
In our investigations one clinical sample could not be classified
correctly by the novel approach. The multiplex assay was designed
on the basis of all 89 known and annotated OPV genomes found
in GenBank (see Table S1) and 24 unpublished OPV genomes
sequenced by whole genome sequencing in our lab. Sanger
sequencing of the longer haemagglutinin ORF (816–957 bases)
identified a CPXV strain in clinical sample number 31. However,
the CPXV strain shows sequence similarity to VACV strains in the
region of the O2L CDS used for multiplex pyrosequencing. The
use of a third amplicon for pyrosequencing could help to obtain
additional information.
Since our method classifies samples based on the similarity of
their pyrosequencing fingerprints to theoretical fingerprints
generated from known sequences, novel mutations cannot be
correctly attributed to a certain species, but can be defined as
unknown, indicating a novel variant of the virus. As can be seen in
Figure 1, it is impossible to reconstruct the individual sequences
from the fingerprint. Thus, any unknown strain – in this case for
instance an OPV with a novel mutation in the sequence regions
used – will generate a fingerprint which is different from all of the
expected fingerprints. Since it is impossible to tell whether this
difference stems from a simple SNP or from major differences in
sequence, the sample will be classified as ‘‘Unknown’’.
It has to be mentioned that a multiplex pyrosequencing assay is
not suitable to identify co-infections with different pathogen
strains. We have demonstrated the applicability of multiplex
pyrosequencing to the identification and classification of human-
pathogenic OPV. This method is applicable to any problem where
samples need to be classified based on nucleic acid sequences. The
possibility to use any number of amplicons with any number of
pyrosequencing primers and thus any number of SNPs means that
even tough problems, where conserved sites with discriminating
SNPs are few and far between, can be successfully tackled.
However, since our method does not correct for the decline of
signal intensity in long pyrosequencing reads, it may not perform
well on assays in which long amplicons need to be sequenced.
We postulate that the method presented in this paper will lead
to a more wide-spread adaptation of multiplex pyrosequencing in
diagnostics, as it allows the quick and cost-effective generation of
high-quality results.
Supporting Information
Figure S1 Screenshots of the program. Left: The program
window after a run xml file has been loaded into the software. A:
The imported plate is shown, the used wells are marked. The raw
data (B: gray graph) and the pre-processed data (C: blue graph) are
displayed. The gray bars in the blue graph show where peaks have
been detected. Right: The program window after a run has been
analyzed. D: Next to the plate graphic the resulting classification
(in this case CPXV1) and the optimum factors of the (two)
pyrosequencing primers are shown. E: Red and blue bars in the
bottom graph visualize how the detected peaks are explained by
the signals expected from the two primers.
(TIFF)
Table S1 List of 89 OPV genomes from NCBI used in the
design of the proof-of-concept assay.
(XLS)
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